在囊性纤维化中肺移植的结果
Nicholas Avdimiretz1, Kieran Halloran2, Christian Benden3,4
1Division of Pediatric Pulmonary, Asthma, and Sleep Medicine, Lucile Packard Children's Hospital, Stanford University, Palo Alto, California, USA.
Current opinion in pulmonary medicine
|July 31, 2024
概括
肺移植 (LTX) 为晚期囊性纤维化肺病 (ACFLD) 患有囊性纤维化肺病 (pwCF) 的人提供了很好的生存率. 然而,CFTR调节器疗法正在减少pwCF中对LTX的需求.
科学领域:
- 肺部病理学 肺部病理学
- 移植手术 移植手术
- 医学遗传学 医学遗传学
背景情况:
- 肺移植 (LTX) 是晚期囊性纤维化肺病 (ACFLD) 的关键干预措施.
- 对于ACFLD来说,LTX已成为所有年龄组的公认治疗方法.
- 本综述侧重于LTX作为囊性纤维化 (CF) 的治疗方法.
研究的目的:
- 审查囊性纤维化作为LTX的首要指示.
- 要突出LTX结果,包括CF患者的存活率和继发症.
- 检查随着时间的推移对CF的LTX的不断变化的格局.
主要方法:
- 目前关于LTX治疗囊性纤维化病的文献的综述.
- 对生存数据和移植后结果的分析.
- 讨论影响结果和并发症的因素.
主要成果:
- 对于患有CF (pwCF) 的人来说,LTX显示出优异的长期存活率,随着时间的推移显著改善.
- 专门的CF护理中心和共同疾病的认可有助于更好的结果.
- 地区之间存在结果差距 (例如,加拿大与加拿大相比). 美国) 和青少年.
- CFTR调节器治疗导致CF的LTX下降,长期影响不确定.
结论:
- 对于ACFLD来说,LTX仍然是一个可行的和被接受的选择,改善了生活质量和生存率.
- 当与患者的护理目标保持一致时,它是一种至关重要的治疗方法.
- CFTR调节器的出现正在重塑LTX在CF管理中的作用.
更多相关视频
09:54Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
1.8K
06:15Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
Published on: November 10, 2023
854
相关概念视频
Cystic Fibrosis: Management
151
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
151
Cystic Fibrosis: Pathogenesis
202
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
202
Pneumothorax-II
131
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
131
